CHIC 2021 will showcase the tremendous progress by the China healthcare industry as well as discuss on-going challenges and opportunities for the future. The discussions will cover a broad spectrum of sub-sectors such as pharmaceuticals, biotechnology, medtech, healthcare services, gene/cell therapy, genomics and artificial intelligence, and offer valuable 1-on-1 sessions for all attendees.
CHIC 2021 will also mark an exciting new partnership with Endpoints News, a global leader in reporting and analyzing the top global biotech and pharmaceutical R&D news of the day.
Endpoints News is an independent news organization, reporting and analyzing the top global biotech and pharmaceutical R&D news of the day. Founded in 2016, Endpoints News has become the way drug development executives stay informed. Reported by a global team of journalists — led by founder John Carroll — Endpoints covers news as it happens and delivers an inimitable twice-daily email report to an engaged audience in the business of discovering, researching, marketing, and regulating biotech drugs. Endpoints News is closely read by professionals at every top 25 pharma company and thousands of startups. Endpoints News is free to read, and Endpoints also offers paid subscriptions for individuals and enterprises that provide exclusive access to premium content. Visit Endpoints News online at endpts.com.
Copyright © 2022 Consortium of China Healthcare. All rights reserved.